Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib-Reference-Cited by-同舟云学术

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

Published:2007-12 Issue:9604 Volume:370 Page:2011-2019
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chu Tammy F,Rupnick Maria A,Kerkela Risto,Dallabrida Susan M,Zurakowski David,Nguyen Lisa,Woulfe Kathleen,Pravda Elke,Cassiola Flavia,Desai Jayesh,George Suzanne,Harris David M,Ismail Nesreen S,Chen Jey-Hsin,Schoen Frederick J,Van den Abbeele Annick D,Demetri George D,Force Thomas,Chen Ming Hui,Morgan Jeffrey A

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Tyrosine kinases as targets for cancer therapy;Krause;N Engl J Med,2005

2. A small molecule-kinase interaction map for clinical kinase inhibitors;Fabian;Nat Biotechnol,2005

3. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate;Kerkelä;Nat Med,2006

4. Targeted cancer therapeutics: the heartbreak of success;Mann;Nat Med,2006

5. Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition;Force;Nat Rev Cancer,2007

Cited by 934 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel imidazo[2,1-b]thiazoles and imidazo[1,2-a]pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: Design, synthesis and biological evaluations;Bioorganic Chemistry;2024-10

2. Cancer and Heart Failure: Dangerous Liaisons;Journal of Cardiovascular Development and Disease;2024-08-27

3. Delineating Drug Class and Target-Specific Adverse Events of Kinase Inhibitors;2024-08-08

4. Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance;Frontiers in Immunology;2024-08-05

5. A multifunctional PEGylated liposomal-encapsulated sunitinib enhancing autophagy, immunomodulation, and safety in renal cell carcinoma;Journal of Nanobiotechnology;2024-07-31